Analyst Consensus ?
ConsensusBuy39 ratings
Bullish2871.8%
Neutral1128.2%
Bearish00.0%
FN2 Earnings Intelligence
Eaton Corporation plc (ETN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Neutral | Upgrade | Sep 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 28, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 11, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 3, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 6, 2026 |
| Keybanc | Overweight | Overweight | Maintain | May 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 6, 2026 |
| HSBC | Buy | Hold | Upgrade | Jan 16, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 9, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Melius Research | Buy | Hold | Upgrade | Sep 15, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 7, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 8, 2025 |
| Jefferies | Buy | Buy | Maintain | Mar 12, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 13, 2024 |
| Argus Research | Buy | Buy | Maintain | May 2, 2024 |
| Berenberg | Buy | Buy | Maintain | Mar 6, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 12, 2023 |
| Oppenheimer | Perform | Outperform | Downgrade | Dec 6, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 2, 2022 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | May 4, 2020 |
| Gordon Haskett | Buy | Hold | Upgrade | Apr 3, 2020 |
| Vertical Research | Buy | Hold | Upgrade | Feb 6, 2020 |
| Baird | Neutral | Neutral | Maintain | Feb 5, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Dec 17, 2019 |
| Vertical Group | Hold | Buy | Downgrade | Oct 9, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 3, 2018 |
| Stifel | Buy | Buy | Maintain | May 3, 2018 |
| Longbow Research | Buy | Neutral | Upgrade | Apr 4, 2017 |
| Buckingham Research | Neutral | Neutral | Maintain | May 2, 2016 |
| Bernstein | Market Perform | Market Perform | Maintain | May 2, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Feb 17, 2016 |
| William Blair | Neutral | Outperform | Downgrade | Oct 15, 2015 |
| MKM Partners | Neutral | Buy | Downgrade | Feb 5, 2014 |
| ISI Group | Buy | Strong Buy | Downgrade | Aug 9, 2013 |
Upside is calculated against the persisted current price $425.37. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $515 | $410.85 | +21.1% | Sep 7, 2026 |
| Morgan Stanley | Toby Okwara | $520 | $416.04 | +22.2% | Aug 28, 2026 |
| Robert W. Baird | Analyst unavailable | $500 | $415.29 | +17.5% | Aug 20, 2026 |
| RBC Capital | Analyst unavailable | $512 | $430.45 | +20.4% | Aug 3, 2026 |
| BMO Capital | Analyst unavailable | $487 | $415.2 | +14.5% | Aug 3, 2026 |
| Evercore ISI | David Raso | $502 | $415.2 | +18.0% | Aug 3, 2026 |
| Evercore ISI | Analyst unavailable | $453 | $401.89 | +6.5% | May 11, 2026 |
| Morgan Stanley | Analyst unavailable | $500 | $401.51 | +17.5% | May 10, 2026 |
| RBC Capital | Analyst unavailable | $484 | $410.6 | +13.8% | May 6, 2026 |
| KeyBanc | Jeffrey Hammond | $480 | $410.86 | +12.8% | May 6, 2026 |
| BMO Capital | Analyst unavailable | $428 | $357.1 | +0.6% | Mar 26, 2026 |
| RBC Capital | Analyst unavailable | $407 | $364.53 | -4.3% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $425 | $371.14 | -0.1% | Feb 4, 2026 |
| HSBC | Sean McLoughlin | $400 | $333.46 | -6.0% | Jan 16, 2026 |
| RBC Capital | Analyst unavailable | $399 | $337 | -6.2% | Jan 15, 2026 |
| Morgan Stanley | Analyst unavailable | $405 | $327.57 | -4.8% | Jan 12, 2026 |
| Barclays | Julian Mitchell | $350 | $332.97 | -17.7% | Jan 7, 2026 |
| UBS | Analyst unavailable | $360 | $327.31 | -15.4% | Jan 4, 2026 |
| Bernstein | Analyst unavailable | $295 | $315.95 | -30.6% | Dec 19, 2025 |
| Wells Fargo | Joseph O'Dea | $340 | $315.82 | -20.1% | Dec 18, 2025 |
| Wolfe Research | Nigel Coe | $413 | $343.39 | -2.9% | Dec 9, 2025 |
| Barclays | Analyst unavailable | $362 | $377.72 | -14.9% | Nov 5, 2025 |
| Mizuho Securities | Analyst unavailable | $425 | $375.59 | -0.1% | Oct 17, 2025 |
| KeyBanc | Jeffrey Hammond | $420 | $375.37 | -1.3% | Oct 14, 2025 |
| Melius Research | Analyst unavailable | $495 | $365.9 | +16.4% | Sep 15, 2025 |
| Raymond James | Deane Dray | $415 | $360.16 | -2.4% | Aug 7, 2025 |
| Bernstein | Chad Dillard | $396 | $359.37 | -6.9% | Jul 14, 2025 |
| BNP Paribas | Andrew Buscaglia | $380 | $326.82 | -10.7% | May 15, 2025 |
| Morgan Stanley | Christopher Snyder | $375 | $298.11 | -11.8% | May 6, 2025 |
| RBC Capital | Deane Dray | $356 | $298.58 | -16.3% | May 5, 2025 |
| Wells Fargo | Joseph O'Dea | $355 | $298.58 | -16.5% | May 5, 2025 |
| Wells Fargo | Joseph O'Dea | $310 | $298.58 | -27.1% | May 5, 2025 |
| Barclays | Analyst unavailable | $315 | $285.52 | -25.9% | Mar 26, 2025 |
| RBC Capital | Analyst unavailable | $376 | $277.55 | -11.6% | Mar 6, 2025 |
| Barclays | Analyst unavailable | $325 | $278.46 | -23.6% | Mar 3, 2025 |
| Wells Fargo | Joseph O'Dea | $335 | $315.41 | -21.2% | Feb 3, 2025 |
| Wells Fargo | Joseph O'Dea | $350 | $343.91 | -17.7% | Jan 7, 2025 |
| Bernstein | Chad Dillard | $382 | $336.75 | -10.2% | Nov 5, 2024 |
| Citigroup | Andrew Kaplowitz | $348 | $305.8 | -18.2% | Sep 16, 2024 |
| Raymond James | Tim Thein | $365 | $284.97 | -14.2% | Sep 9, 2024 |
| Morgan Stanley | Chris Snyder | $370 | $285.72 | -13.0% | Sep 6, 2024 |
| Jefferies | Stephen Volkmann | $385 | $329.55 | -9.5% | Jul 11, 2024 |
| Mizuho Securities | Brett Linzey | $355 | $313.46 | -16.5% | May 1, 2024 |
| RBC Capital | Deane Dray | $371 | $320.16 | -12.8% | Apr 4, 2024 |
| Barclays | Julian Mitchell | $300 | $312.03 | -29.5% | Apr 2, 2024 |
| RBC Capital | Deane Dray | $286 | $300.29 | -32.8% | Mar 14, 2024 |
| Morgan Stanley | Analyst unavailable | $175 | $161.77 | -58.9% | Jan 6, 2023 |
| Wells Fargo | Analyst unavailable | $163 | $156.61 | -61.7% | Jan 5, 2023 |
| Barclays | Analyst unavailable | $130 | $158.82 | -69.4% | Jan 5, 2023 |
| Credit Suisse | John Walsh | $167 | $152.33 | -60.7% | Aug 15, 2022 |
| UBS | Analyst unavailable | $173 | $147.65 | -59.3% | Aug 3, 2022 |
| Mizuho Securities | Analyst unavailable | $160 | $146.92 | -62.4% | Aug 3, 2022 |
| Barclays | Analyst unavailable | $124 | $147.48 | -70.8% | Aug 3, 2022 |
| Mizuho Securities | Analyst unavailable | $145 | $128.52 | -65.9% | Jul 18, 2022 |
| Deutsche Bank | Analyst unavailable | $156 | $125.76 | -63.3% | Jul 13, 2022 |
| Wells Fargo | Analyst unavailable | $139 | $126.88 | -67.3% | Jul 13, 2022 |
| Wells Fargo | Joseph O’Dea | $142 | $127.87 | -66.6% | Jul 11, 2022 |
| Barclays | Analyst unavailable | $112 | $129.59 | -73.7% | Jul 8, 2022 |
| Goldman Sachs | Analyst unavailable | $146 | $126.22 | -65.7% | Jun 23, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $170 | $141.36 | -60.0% | Jun 7, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $180 | $143.38 | -57.7% | May 17, 2022 |
| Morgan Stanley | Analyst unavailable | $174 | $145.26 | -59.1% | May 4, 2022 |
| Wells Fargo | Analyst unavailable | $159 | $147.03 | -62.6% | May 4, 2022 |
| Barclays | Analyst unavailable | $145 | $146.58 | -65.9% | May 4, 2022 |
| Oppenheimer | Christopher Glynn | $170 | $146.41 | -60.0% | May 2, 2022 |
| Deutsche Bank | Nicole DeBlase | $175 | $140.66 | -58.9% | Apr 19, 2022 |
| Barclays | Julian Mitchell | $155 | $146.61 | -63.6% | Apr 5, 2022 |
| Evercore ISI | David Raso | $181 | $153.36 | -57.4% | Feb 21, 2022 |
| Wolfe Research | Nigel Coe | $194 | $149.31 | -54.4% | Feb 7, 2022 |
| Berenberg Bank | Phil Buller | $200 | $169.63 | -53.0% | Nov 5, 2021 |
| Oppenheimer | Christopher Glynn | $185 | $167.84 | -56.5% | Nov 3, 2021 |
| Citigroup | Timothy Thein | $180 | $150.14 | -57.7% | Oct 12, 2021 |
| HSBC | Puneet Garg | $153 | $154.77 | -64.0% | Sep 14, 2021 |
| Goldman Sachs | Joe Ritchie | $186 | $158.82 | -56.3% | Sep 10, 2021 |
| UBS | Markus Mittermaier | $186 | $164.53 | -56.3% | Aug 11, 2021 |
| Argus Research | John Eade | $185 | $164.96 | -56.5% | Aug 10, 2021 |
| Bank of America Securities | Andrew Obin | $195 | $159.52 | -54.2% | Aug 4, 2021 |
| J.P. Morgan | Ann Duignan | $145 | $151.84 | -65.9% | Jul 13, 2021 |
Track every rating change on ETN the moment it posts. Free to start.
Start free